The National Cancer Institute is offering the Pediatric Immunotherapy Translational Science Network (PI-TSN) Grant to accelerate cancer research for children and adolescents. This grant aims to establish a network of investigators focusing on new targets for immunotherapies, developing pediatric immunotherapy treatment approaches, and understanding how pediatric tumors evade the immune system. The grant solicits U01 applications for research projects addressing mechanisms of immune evasion and more. Successful applicants will join the Pediatric Immunotherapy Discovery and Development Network to implement recommendations for pediatric immunotherapy research.
Opportunity ID: 297682
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-CA-17-051 |
Funding Opportunity Title: | Pediatric Immunotherapy Translational Science Network (PI-TSN)(U01) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.395 — Cancer Treatment Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Sep 26, 2017 |
Last Updated Date: | – |
Original Closing Date for Applications: | Dec 19, 2017 |
Current Closing Date for Applications: | Dec 19, 2017 |
Archive Date: | Jan 24, 2018 |
Estimated Total Program Funding: | $4,000,000 |
Award Ceiling: | $500,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | County governments City or township governments Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities For profit organizations other than small businesses Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Private institutions of higher education State governments Independent school districts |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The overall goal of this FOA and the companion FOA, RFA-CA-17-050, is to establish a network of collaborating investigators to identify and advance research opportunities for translating immunotherapy concepts for children and adolescents with cancer toward clinical applications. Specifically, this FOA targets the following area(s) designated as a scientific priority(ies) by the Blue Ribbon Panel (BRP): Recommendation (B) that calls for the establishment of a pediatric immunotherapy translation science network. The network was envisioned by the BRP as focusing on identifying new targets for immunotherapies, developing new pediatric immunotherapy treatment approaches (e.g., cancer vaccines, cellular therapy, combinations of immunotherapy agents, and others), and defining the biological mechanisms by which pediatric tumors evade the immune system. This FOA solicits U01 applications for discrete research projects that address relevant research opportunities (e.g., mechanisms of immune evasion, model development, validation of a single target, etc.), while the companion FOA, RFA-CA-17-050, solicits multi-component U54 Center applications. Successful applicants from both FOAs will become members of the Pediatric Immunotherapy Discovery and Development Network (PI-DDN), which will address and implement the BRP recommendations. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-17-051.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-D | Use for due dates on or after May 25, 2016 | PKG00234956 | Nov 19, 2017 | Dec 19, 2017 | View |
Package 1
Mandatory forms
297682 RR_SF424_2_0-2.0.pdf
297682 PHS398_CoverPageSupplement_3_0-3.0.pdf
297682 RR_OtherProjectInfo_1_3-1.3.pdf
297682 PerformanceSite_2_0-2.0.pdf
297682 RR_KeyPersonExpanded_2_0-2.0.pdf
297682 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
297682 RR_Budget_1_3-1.3.pdf
297682 RR_SubawardBudget30_1_3-1.3.pdf
297682 PHS398_ModularBudget_1_2-1.2.pdf
297682 PHS_Inclusion_Enrollment_Report-1.0.pdf
297682 PHS_AssignmentRequestForm-1.0.pdf